| Dr Naofiumi Takemoto, MD | |
|
1460 N Center Rd, Burton, MI 48509-1429 | |
| (810) 715-4300 | |
| Not Available |
| Full Name | Dr Naofiumi Takemoto |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1460 N Center Rd, Burton, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033284880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301088623 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Naofiumi Takemoto, MD 1460 N Center Rd, Burton, MI 48509-1429 Ph: (810) 715-4300 | Dr Naofiumi Takemoto, MD 1460 N Center Rd, Burton, MI 48509-1429 Ph: (810) 715-4300 |
News Archive
Researchers from the University of Granada and RMIT University in Melbourne have developed personalized and low-cost wearable ultraviolet sensors that warn users when their exposure to the sun has become dangerous.
Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order for an effective amount to reach the target.
Most flu immunization plans in the United States do not address how to vaccinate hard-to-reach populations (HTR)-undocumented immigrants, substance users, the homeless, homebound elderly, and minorities-and this potentially dangerous omission can lead masses of people to become ill during an outbreak of pandemic flu or other contagious disease, according to a new study by the New York Academy of Medicine in the current issue of the Journal of Urban Health.
BioChemics, Inc. (BCI) has announced the signing of a research collaboration agreement with Pacific Pharmaceutical Co., Ltd, a publicly held Company in South Korea to evaluate the use of BCI's VALE® based compositions in cosmetic applications.
Global biotherapeutics leader CSL Behring announced today that the company has submitted its new drug application to Japan's Pharmaceuticals and Medical Devices Agency for its investigational fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP).
› Verified 3 days ago
Dr. Daniel Steven Edwin Rode, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1460 N Center Rd, Burton, MI 48509 Phone: 810-715-4300 | |
Bineh-karan Singh Kalra, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1460 N Center Rd, Burton, MI 48509 Phone: 810-715-4300 | |
Alex Suchorab, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1460 N Center Rd, Burton, MI 48509 Phone: 810-715-4300 | |
Dr. Clarissa Kroese, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1460 N Center Rd, Burton, MI 48509 Phone: 810-715-4300 | |
Dr. Christopher Weston Cenzer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1460 N Center Rd, Burton, MI 48509 Phone: 810-715-4300 | |
Dr. James Lum, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1096 S Belsay Rd, Suite D, Burton, MI 48509 Phone: 810-743-3880 Fax: 810-743-3886 |